Atika Capital Management LLC Jazz Pharmaceuticals PLC Transaction History

Atika Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$133.98 - $160.47 $8.43 Million - $10.1 Million	-62,907 Reduced 70.36%	26,500 $3.88 Million
Q4 2022 Feb 13, 2023	SELL	$129.72 - $159.85 $5.27 Million - $6.49 Million	-40,593 Reduced 31.23%	89,407 $14.2 Million
Q3 2022 Nov 14, 2022	SELL	$126.59 - $161.18 $4.94 Million - $6.29 Million	-39,000 Reduced 23.08%	130,000 $17.3 Million
Q2 2022 Aug 12, 2022	SELL	$141.59 - $168.66 $4.25 Million - $5.06 Million	-30,000 Reduced 15.08%	169,000 $26.4 Million
Q1 2022 May 13, 2022	BUY	$129.64 - $160.7 $25.8 Million - $32 Million	199,000 New	199,000 $31 Million
Q4 2017 Feb 14, 2018	SELL	$131.06 - $150.39 $1.9 Million - $2.18 Million	-14,500 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	$142.62 - $155.6 $570,480 - $622,400	-4,000 Reduced 21.62%	14,500 $2.12 Million
Q2 2017 Aug 14, 2017	BUY	N/A	18,500	18,500 $2.88 Million

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Atika Capital Management LLC with notifications on news.